Global Community

Investment Memo – Roche Holding AG (Pharmaceutical Division / “Roche Pharma”) 1. Executive Summary Roche is a leading global pharmaceutical and diagnostics company with a strong focus on oncology, immunology, neuroscience, and rare diseases.Read more

The Game-Changing Executive Order: A $11.4B Company's Perfect Storm Sometimes the stars align in ways that even the most astute investors couldn't predict. For IREN Limited (NASDAQ: IREN), currently valued at $11.4 billion with shares trading around $42 , the Trump Administration's July 23rd Executive Order on data centre permitting represents exactly that kind of celestial convergence.Read more

Equity Research: Glenveagh Properties PLC (GVR:ID) Data Ingestion & Variable Binding Company Name & Ticker: Glenveagh Properties PLC (GVR:ID) Current Market Price: €2.27 Trailing 12M Revenue (FY 2024): €869.0 Million Fundamental Valuation Method: DCF / NAV Hybrid Model Revenue Growth: Modeled at 15-20% annualized, bridging to ~2,500+ unit completions in FY 2025/2026. Margins: Suburban gross margins assumed at 21.2% (FY24 actuals), trending toward 22%+ due to scale and MMC (NUA Manufacturing).Read more

Amadeus IT (AMS.MC): The "AI Fear" Arbitrage Opportunity Current Price: ~€48.84 | Target Range: €62.00 – €75.00 | View: Strong Buy / Accumulate The market has priced Amadeus as a "terminal decline" asset due to fears of AI disintermediation. However, operational reality contradicts this narrative.Read more

Q1 FY9/26 results update Stellar start to the year – Q1 FY9/26 results saw MRI record OP surging 133.5% YoY and RP rising 99.0% YoY, driven by healthy top-line growth and minimal incremental costs. GPM reached 27.3%, and OPM climbed to 11.2%.Read more

Initiating coverage Institutional backing validates Japan's first Ethereum-focused DAT – Quantum Solutions has secured US$150mn in committed capital from Susquehanna International Group and ARK Invest, making it the only Tokyo-listed DAT backed by these institutional investors. The strategic pivot to Ethereum positions the Company to capitalize on the growing adoption of DeFi and Real World Asset tokenization among institutions.Read more

Originally posted on the Woodworth Contrarian Fund Website here: https://www.woodworth.fund/news/less-drama-more-ketchup Kraft Heinz is not suddenly a glamour stock, and that is precisely what makes it interesting. The first-quarter update did not offer some miraculous reinvention; instead, it offered something much more useful: evidence that the company is still throwing off cash, still protecting the dividend, and finally spending more time building brands than contemplating corporate dismemberment.Read more

Executive Summary: Under base-case assumptions – Brent crude stabilising at ~$70/bbl by 2027, PetroTal’s production exceeding 20,000 bopd, and a P/E ~10 – PetroTal’s stock is poised to roughly double by 2027–2028 (into the $0.8–$1.0/share range). This upside is driven by robust output growth and a re-rating from today’s low valuation (the stock trades at low multiples vs.Read more

Rating: Highly Speculative / Selective buy on pullbacks Style: Quantum hardware optionality Core debate: Is Rigetti becoming a credible superconducting quantum hardware contender with improving commercialization and a much stronger balance sheet, or is the stock still far ahead of the company’s real economic progress? Executive view Rigetti looks better today than it did in the prior version of the thesis, mainly because the company now has a fresher proof point: Q1 2026 revenue of $4.4 million , up sharply year over year, helped by Novera system deliveries , while still maintaining $569 million of cash, cash equivalents, and investments and zero debt.Read more